Onkologie. 2011:5(5):261-266

Epidemiology, etiology, screening and diagnosis of colorectal cancer, including

Štěpán Suchánek1, Gabriela Vepřeková1, Ondřej Májek2, Ladislav Dušek2, Miroslav Zavoral1
1 Univerzita Karlova, 1. lékařská fakulta, Ústřední vojenská nemocnice, Interní klinika, Praha
2 Masarykova Univerzita, Institut biostatistiky a analýz, Brno

the therapeutic procedures in colon and rectum

Colorectal cancer (CRC) is the second most common malignant disease in the European Union countries. It is a genetic disorder which

is characterized by gradual accumulation of changes which lead to uncontrolled cell growth. Currently there are three paths of cancerogenesis

known: chromosomal and microsatellite instability and CpG islands methylation. Majority of CRCs (80–85 %) are represented

by the sporadic form with the age as the most important risk factor. Only 14–19 % of CRCs rise from inherited predisposition. Due to the

relative long time of cancerogenesis, the detection of premalignant lesions by screening is crucial. The basic screening methods are

fecal occult blood tests and colonoscopy. Colonoscopy examination is important in surveillance of CRC high risk patients and therapy

(adenomatous polyps removal). The strict quality control recommended on diagnostic (adenoma detection rate, complete examinations)

and therapeutic (prevention of complications such as perforation and bleeding) level is essential. It can be believed that due to

the national CRC screening program (carried out since year 2000), the CRC mortality in the Czech Republic has been stabilized for long

time. To its lowering, the highest participation of target population is necessary. It can be achieved by intensive participation of medical

specialists and the executive.

Keywords: colorectal cancer, cancerogenesis, colonoscopy, FOBT, surveillance

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Suchánek Š, Vepřeková G, Májek O, Dušek L, Zavoral M. Epidemiology, etiology, screening and diagnosis of colorectal cancer, including. Onkologie. 2011;5(5):261-266.
Download citation

References

  1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v 1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. [Internet] 2010 [cited 28.7.2011]; dostupné na: http://globocan.iarc.fr.
  2. Lengauer C, Kinzler K, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396(6712): 643-649. Go to original source... Go to PubMed...
  3. Pino M, Chung D. The chromosomal instability pathway in colon cancer. Gastroenterology 2010; 138(6): 2059-2072. Go to original source... Go to PubMed...
  4. Fearon E, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5): 759-767. Go to original source... Go to PubMed...
  5. Wood L, Parsons D, Vogelstein B, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318(5853): 1108-1113. Go to original source... Go to PubMed...
  6. Leary R, Lin J, Velculescu V, et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proceedings Of The National Academy Of Sciences Of The United States Of America 2008; 105(42): 16224-16229. Go to original source...
  7. Popat S, Hubner R, Houlston R. Systematic review of microsatellite instability and colorectal cancer prognosis. Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology 2005; 23(3): 609-618. Go to original source... Go to PubMed...
  8. Hampel H, Frankel W, de la Chapelle A, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). The New England Journal Of Medicine 2005; 352(18): 1851-1860. Go to original source... Go to PubMed...
  9. Boland C, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138(6): 2073-2087. Go to original source... Go to PubMed...
  10. Sinicrope F, Rego R, Witzig T, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006; 131(3): 729-737. Go to original source... Go to PubMed...
  11. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138(6): 2088-2100. Go to original source... Go to PubMed...
  12. Chan A, Giovannucci E. Primary prevention of colorectal cancer. Gastroenterology 2010; 138(6): 2029-2043. Go to original source... Go to PubMed...
  13. Shoelson S, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132(6): 2169-2180. Go to original source... Go to PubMed...
  14. Chan A, Ogino S, Fuchs C. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. The New England Journal Of Medicine 2007; 356(21): 2131-2142. Go to original source... Go to PubMed...
  15. Bertagnolli M, Eagle C, Adenoma Prevention with Celecoxib Study I, et al. Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer prevention research 2009; 2(4): 310-321. Go to original source... Go to PubMed...
  16. Labayle D, Fischer D, Attali P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101(3): 635-639. Go to original source... Go to PubMed...
  17. Rossouw J, Anderson G, Writing Group for the Women's Health Initiative I, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA: the journal of the American Medical Association 2002; 288(3): 321-333. Go to original source... Go to PubMed...
  18. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, Fric P. Colorectal cancer screening in Europe. Journal Of Gastroenterology 2009; 47(15): 5907-5915. Go to original source... Go to PubMed...
  19. Eliakim R, Yassin K, Adler S, et al. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy. Endoscopy 2009; 41(12): 1026-1031. Go to original source... Go to PubMed...
  20. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U. S. population. Cancer 2004; 100: 2093-2103. Go to original source... Go to PubMed...
  21. Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B, Wasco KE, A consensus document on before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surgical Endoscopy 2006; 20(7): 1147-60. Go to original source... Go to PubMed...
  22. Church JM. Effectiveness of polyethylene glycol antegrade gut lavage bowel preparation for colonoscopy - timing is the key! Diseases of the colon and rectum 1998; 41(10): 1223-1225. Go to original source... Go to PubMed...
  23. Hendry PO, Jenkins JT, Diament RH. The impact of poor bowel preparation on colonoscopy: a prospective single centre study of 10 571 colonoscopies. Colorectal Disease 2007; 9: 745-748. Go to original source... Go to PubMed...
  24. Barclay R, Vicari J, Doughty A, Johanson J, Greenlaw R. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. The New England Journal Of Medicine 2006; 355(24): 2533-2541. Go to original source... Go to PubMed...
  25. van Rijn J, Reitsma J, Stoker J, Bossuyt P, van Deventer S, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. The American Journal Of Gastroenterology 2006; 101(2): 343-350. Go to original source... Go to PubMed...
  26. Kiesslich R, Goetz M, Neurath M, et al. Chromoscopyguided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007; 132(3): 874-882. Go to original source... Go to PubMed...
  27. Wallace M, Kiesslich R. Advances in endoscopic imaging of colorectal neoplasia. Gastroenterology 2010; 138(6): 2140-2150. Go to original source... Go to PubMed...
  28. Baron JA, Sandler RS, Bresalier RS, Quan H, Riddell R, Lanas A, Bolognese JA, Oxenius B, Horgan K, Loftus S & Morton DG. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas, Gastroenterology 2006; 131(6): 1674-1682. Go to original source... Go to PubMed...
  29. Martinez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DJ, Smith-Warner SA, Jacobs ET, Alberts DS & Greenberg ER. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy, Gastroenterology 2009; 136(3): 832-841. Go to original source... Go to PubMed...
  30. Rosen L, Bub DS, Reed JF, III & Nastasee SA. Hemorrhage following colonoscopic polypectomy, Dis Colon Rectum 1993; 36(12): 1126-1131. Go to original source... Go to PubMed...
  31. Atkin W, Valori R, Kuipers EJ, et al. Colonoscopic surveillance following adenoma removal. In: Segnan N, Patnick J, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis, 1st ed., European Union, 2010: 274-297, doi: 10.2772/1458.
  32. Parra-Blanco A, Kaminaga N, Kojima T, Endo Y, Tajiri A, Fujita R. Colonoscopic polypectomy with cutting current: is it safe? Gastrointest. Endosc 2000; 51(6): 676-681. Go to original source... Go to PubMed...
  33. Cotton PB, Williams CB. Colonoscopic polypectomy and procedures. In Practical Gastroentestinal Endoscopy (4th Edition), Blackwell Science, 1996: 257-302.
  34. Hsieh YH, Lin HJ, Tseng GY, Perng CL, Li AF, Chang FY, Lee SD. Is submucosal epinephrine injection necessary before polypectomy? A prospective, comparative study, Hepatogastroenterology 2001; 48(41): 1379-1382. Go to PubMed...
  35. Brandimarte G, Tursi A. Endoscopic snare excision of large pedunculated colorectal polyps: a new, safe and effective technique, Endoscopy 2001; 33(10): 854-857. Go to original source... Go to PubMed...
  36. Boix J, Lorenzo-Zuniga V, Moreno dV, Vananos FE, Domenech E, Ojanguren I, Gassull MA. Endoscopic removal of large sessile colorectal adenomas: is it safe and effective? Dig Dis Sci 2007; 52(3): 840-844. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.